BIOXYNE LIMITED — Board/Management Information 2017

Jun 12, 2017

==> picture [596 x 109] intentionally omitted <==

----- Start of picture text ----- Suite 506, Level 5, 50 Clarence StSydney NSW 2000P: +61 2 9078 8180W: www.bioxyne.com----- End of picture text -----

ASX Announcement 13 June 2017

Appointment of Directors

Following the successful completion of the recent rights issue Bioxyne Limited (ASX: BXN) is pleased to announce the appointment of Mr NH Chua and Mr Maxwell Parkin as Directors of the Company[1] .

Mr NH Chua

Mr Chua, who has also been appointed Chief Executive Officer, was Vice President of Asia Pacific for New Image Limited (previously listed on NZX), a position he held successfully for over 10 years. Mr Chua commenced his direct sales career in 1985 when he successfully launched First Image Sdn Bhd in Malaysia which later became a successful retailing company selling the Total Image brand of Health Care Products. In 1989, he set up a new network marketing company, Abric Image Sdn Bhd. This company was subsequently acquired by New Image Limited prior to it being listed on the NZX.

Mr Chua is fluent in Malay, Indonesian, Mandarin and several other dialects of Chinese. He has a BA in Economics and Commerce from the University of Toronto.

Mr Maxwell Parkin

Mr Parkin has over 35 years’ experience of dairy management and consulting experience in New Zealand, Australia, China and South East Asia Pacific, the Americas, Africa and the Middle East.

Mr Parkin’s former dairy industry roles included Group General Manager, Manufacturing, Fonterra; Director International Manufacturing, Fonterra and CEO of Southland Dairy Cooperative Company Limited. He also served on the Board of the NZ Dairy Research Institute.

Mr Parkin was a former non-executive director of the then listed New Image Limited, prior to that company being privatised, and is currently a director of Miraka Limited and Chairman of Combined Technologies Limited.

The Board of Bioxyne now comprises:

Anthony Ho – Chairman NH Chia – Managing Director and CEO Patrick Ford – Non-executive Director Dr Peter French – Scientific Director Maxwell Parkin – Executive Director

Anthony Ho Chairman

1 ASX Announcement 19 April 2017

About Bioxyne

Bioxyne Limited (ASX:BXN) is an Australian life sciences and health products company with a focus on immune health and immunotherapeutic products.

Through our recent acquisition in New Zealand, now trading as Bioxyne International, we are further developing a range of existing functional foods and beauty products containing ingredients sourced exclusively from New Zealand, for our direct sales channel.

Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC®. Bioxyne is a company creating value for consumers and investors by delivering safe and effective solutions.

Bioxyne’s focus is currently on the company’s probiotic business and proprietary product Lactobacillus fermentum PCC® which is supported by a manufacturing and distribution agreement with Chr. Hansen (Denmark) a global leader in the manufacturing of natural food additives and supplements products for the food, health, pharmaceutical and agriculture industries.

Bioxyne also has a distribution agreement with Nu-Skin Enterprises (USA) a successful worldwide multilevel marketing company who pride themselves in offering only quality solutions to their customers.

Tony Ho Guy Robertson Non-executive Chairman Company Secretary Mob: +61 417 345 839 Mob: +61 407 983 270